A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Inclusion Criteria:

- Subjects ≥ 18 years of age, mentally competent, in good health as determined by
medical history, physical examination and clinical judgment by the Investigator; able
to comply with all study procedures, to be contacted, and to be available for study
visits according to the protocol.

Exclusion Criteria:

- Individuals who are pregnant or breastfeeding. Female subjects of childbearing
potential must have a negative pregnancy test prior to study vaccines being
administered.

- Females of childbearing potential who refuse to use an acceptable method of birth
control from Day 1 (1st vaccination) to 3 weeks after the second study vaccination,
and, if sexually active, who have not used a reliable birth control method for at
least two months prior to study entry.

- Individuals with a body temperature ≥38.0 °C (≥100.4 °F) or any acute illness within 3
days of intended study vaccination.

- Individuals who received any type of influenza vaccine (e.g., "seasonal") within 7
days prior to enrolment in this study or who are planning to receive any type of
influenza vaccine within 7 days (before or after) from the study vaccines.

- Individuals who received any other licensed vaccines within 14 days (for inactivated
vaccines) or 28 days (for live vaccines) prior to enrollment in this study or who are
planning to receive any (non-influenza) vaccine within 28 days (before or after) from
the study vaccines.

- Individuals with known or suspected impairment of the immune system.